S&P 500
(0.13%) 5 187.70 points
Dow Jones
(0.08%) 38 884 points
Nasdaq
(-0.10%) 16 333 points
Oil
(-0.22%) $78.21
Gas
(0.32%) $2.21
Gold
(-0.08%) $2 322.30
Silver
(-0.20%) $27.49
Platinum
(0.21%) $990.50
USD/EUR
(0.05%) $0.930
USD/NOK
(0.26%) $10.93
USD/GBP
(0.10%) $0.800
USD/RUB
(0.02%) $91.46

Aktualne aktualizacje dla Indivior PLC [INDV.L]

Giełda: LSE Branża: Pharmaceuticals, Biotechnology & Life Sciences
Ostatnio aktualizowano7 geg. 2024 @ 18:37

-0.91% £ 1 422.00

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 18:37):

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders...

Stats
Dzisiejszy wolumen 300 150
Średni wolumen 511 646
Kapitalizacja rynkowa 1.93B
EPS £0 ( 2024-04-24 )
Następna data zysków ( £0 ) 2024-07-25
Last Dividend £36.50 ( 2016-06-16 )
Next Dividend £0 ( N/A )
P/E 1 422.00
ATR14 £1.896 (0.13%)

Wolumen Korelacja

Długi: 0.11 (neutral)
Krótki: 0.83 (strong)
Signal:(45.432) Same movement expected

Indivior PLC Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Indivior PLC Korelacja - Waluta/Towar

The country flag -0.62
( weak negative )
The country flag -0.57
( weak negative )
The country flag -0.63
( weak negative )
The country flag -0.49
( neutral )
The country flag 0.62
( weak )
The country flag 0.64
( weak )

Indivior PLC Finanse

Annual 2023
Przychody: £1.09B
Zysk brutto: £907.00M (82.98 %)
EPS: £0.0100
FY 2023
Przychody: £1.09B
Zysk brutto: £907.00M (82.98 %)
EPS: £0.0100
FY 2022
Przychody: £901.00M
Zysk brutto: £742.00M (82.35 %)
EPS: £-0.380
FY 2021
Przychody: £791.00M
Zysk brutto: £664.00M (83.94 %)
EPS: £1.410

Financial Reports:

No articles found.

Indivior PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Indivior PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.95 - low (64.48%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend £10.40 2015-09-17
Last Dividend £36.50 2016-06-16
Next Dividend £0 N/A
Payout Date 2016-07-29
Next Payout Date N/A
# dividends 2 --
Total Paid Out £46.90 --
Avg. Dividend % Per Year 0.00% --
Score 1.12 --
Div. Sustainability Score 4.95
Div.Growth Potential Score 0
Div. Directional Score 1.992 --
Next Divdend (Est)
(2024-07-15)
£0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.12
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £0 0.00%
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RTO.L Dividend Knight 2023-08-03 Annually 32 0.88%
HILS.L Dividend King 2023-11-30 Semi-Annually 32 1.26%
AXI.L Dividend Knight 2023-08-03 Quarterly 9 4.00%
VP.L Dividend Knight 2023-06-22 Annually 33 2.60%
MSLH.L Dividend Knight 2023-10-19 Annually 33 1.56%
DNLM.L Dividend King 2023-10-26 Semi-Annually 18 3.31%
SKG.L Dividend King 2023-09-28 Semi-Annually 17 2.40%
IMB.L Dividend King 2023-08-17 Quarterly 28 4.66%
BOWL.L Dividend Knight 2023-06-08 Annually 8 1.03%
ORIT.L Dividend Knight 2023-08-17 Quarterly 5 2.77%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.001831.5009.9610.00[0 - 0.5]
returnOnAssetsTTM0.001021.2009.9710.00[0 - 0.3]
returnOnEquityTTM0.005421.500-1.051-1.576[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM0.9680.800-0.161-0.129[1 - 3]
quickRatioTTM0.5260.800-1.609-1.287[0.8 - 2.5]
cashRatioTTM0.2421.5009.7710.00[0.2 - 2]
debtRatioTTM0.144-1.5007.59-10.00[0 - 0.6]
interestCoverageTTM0.5531.000-0.906-0.906[3 - 30]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
freeCashFlowPerShareTTM-2.682.00-1.339-2.68[0 - 20]
debtEquityRatioTTM0.215-1.5009.14-10.00[0 - 2.5]
grossProfitMarginTTM0.8301.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.01921.000-1.616-1.616[0.1 - 0.6]
cashFlowToDebtRatioTTM-1.1171.000-7.32-7.32[0.2 - 2]
assetTurnoverTTM0.5590.8009.607.68[0.5 - 2]
Total Score4.95

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM1 238.721.00010.000[1 - 100]
returnOnEquityTTM0.005422.50-0.676-1.576[0.1 - 1.5]
freeCashFlowPerShareTTM-2.682.00-0.892-2.68[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.2881.000-9.700[0.1 - 0.5]
Total Score-0.971

Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej